Vidjongtius, Enseval's president director, said the company targets to raise rights issue proceeds of Rp200-300 billion which will be used for funding the expansion of distribution network and logistic in some areas.
He said the company schedules to hold extraordinary general shareholders meeting in March 2, 2011 for seeking approval for rights issue.
Enseval targets its revenue to grow 12-15% this year. As of September 2010, the company booked revenue of Rp6.9 trillion.
The distribution of Kalbe Farma's products contributed 72% of total Enseval's revenue while the rest came from the selling and distribution of other companies' products. Kalbe Farma holds 83.75% stake in Enseval.
He said the company schedules to hold extraordinary general shareholders meeting in March 2, 2011 for seeking approval for rights issue.
Enseval targets its revenue to grow 12-15% this year. As of September 2010, the company booked revenue of Rp6.9 trillion.
The distribution of Kalbe Farma's products contributed 72% of total Enseval's revenue while the rest came from the selling and distribution of other companies' products. Kalbe Farma holds 83.75% stake in Enseval.
Tidak ada komentar:
Posting Komentar